Compumedics (ASX:CMP) Cyclically Adjusted Price-to-FCF: (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:CMP Compumedics Ltd ASX:CMP
49 GF Score
Price A$0.26
GF Value A$0.30
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Compumedics Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Compumedics  (ASX:CMP) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Compumedics Cyclically Adjusted Price-to-FCF Related Terms


Compumedics Cyclically Adjusted Price-to-FCF Historical Data

* Premium members only.

The historical data trend for Compumedics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Cyclically Adjusted Price-to-FCF Chart

Compumedics Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.13 0.00 0.00 0.00 0.00

Compumedics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:CMP vs ABT, SYK, MDT: Cyclically Adjusted Price-to-FCF Comparison

For the Medical Devices subindustry, Compumedics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compumedics Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Compumedics's Cyclically Adjusted Price-to-FCF falls into.


ASX:CMP
49GF Score
Compumedics Ltd ASX:CMP
Cyclically Adjusted Price-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Compumedics's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jun26 is calculated as:

For example, Compumedics's adjusted Free Cash Flow per Share data for the fiscal year that ended in Jun26 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun26 (Change)*Current CPI (Jun26)
=0.014/136.4868*136.4868
=0.014

Current CPI (Jun26) = 136.4868.

Compumedics Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201706 -0.002 0.000
201806 -0.008 0.000
201906 0.005 0.000
202006 0.007 0.000
202106 -0.001 0.000
202206 0.002 0.000
202306 -0.025 0.000
202406 -0.017 0.000
202506 -0.037 131.551 -0.038
202606 0.014 136.487 0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.26 is trading 15% below its estimated GF Value™ of A$0.30. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • Cyclically Adjusted Price-to-FCF:
  • GF Value™: A$0.30 vs. price of A$0.26 (15% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
49GF Score

Get the complete analysis for ASX:CMP

Cyclically Adjusted Price-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.26
Price
A$0.30
GF Value